HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.

Abstract
A prototype Shigella human immunodeficiency virus type 1 (HIV-1) gp120 DNA vaccine vector was constructed and evaluated for immunogenicity in a murine model. For comparative purposes, mice were also vaccinated with a vaccinia virus-env (vaccinia-env) vector or the gp120 DNA vaccine alone. Enumeration of the CD8(+)-T-cell responses to gp120 after vaccination using a gamma interferon enzyme-linked spot assay revealed that a single intranasal dose of the Shigella HIV-1 gp120 DNA vaccine vector elicited a CD8(+) T-cell response to gp120, the magnitude of which was comparable to the sizes of the analogous responses to gp120 that developed in mice vaccinated intraperitoneally with the vaccinia-env vector or intramuscularly with the gp120 DNA vaccine. In addition, a single dose of the Shigella gp120 DNA vaccine vector afforded significant protection against a vaccinia-env challenge. Moreover, the number of vaccinia-env PFU recovered in mice vaccinated intranasally with the Shigella vector was about fivefold less than the number recovered from mice vaccinated intramuscularly with the gp120 DNA vaccine. Since the Shigella vector did not express detectable levels of gp120, this report confirms that Shigella vectors are capable of delivering passenger DNA vaccines to host cells and inducing robust CD8(+) T-cell responses to antigens expressed by the DNA vaccines. Furthermore, to our knowledge, this is the first documentation of antiviral protective immunity following vaccination with a live Shigella DNA vaccine vector.
AuthorsM T Shata, D M Hone
JournalJournal of virology (J Virol) Vol. 75 Issue 20 Pg. 9665-70 (Oct 2001) ISSN: 0022-538X [Print] United States
PMID11559798 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • AIDS Vaccines
  • Antigens, Viral
  • HIV Envelope Protein gp120
  • Vaccines, DNA
Topics
  • AIDS Vaccines (administration & dosage, immunology)
  • Administration, Intranasal
  • Animals
  • Antigens, Viral (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Disease Models, Animal
  • Female
  • Genetic Vectors (administration & dosage)
  • HIV Envelope Protein gp120 (genetics, immunology)
  • HIV Infections (immunology, prevention & control)
  • HIV-1 (immunology)
  • Lymphocyte Count
  • Mice
  • Mice, Inbred BALB C
  • Shigella (genetics)
  • Vaccination
  • Vaccines, DNA (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: